Search results
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
WLNS Lansing· 5 days agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 3 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 3 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 3 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 3 days agoPharmaceutical segment revenues beat the Zacks Consensus Estimate of $13.53 billion and our model...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 3 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 4 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
Merck Beats on Earnings a Month After Major Drug Approval. The Stock Is Rising.
Barrons.com· 3 days agoFEATURE Sales of Merck ‘s blockbuster cancer drug Keytruda jumped 20% in the first quarter of the...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 3 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda...